O'Shaughnessy Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

O'Shaughnessy Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.23M	Sell	25,864 -8,571	-25%	-$1.88M	0.03%	495
2026 Q1	$6.51M	Sell	34,435 -1,132	-3%	-$198K	0.03%	463
2025 Q4	$6.05M	Buy	35,567 +1,775	+5%	+$272K	0.03%	463
2025 Q3	$4.45M	Sell	33,792 -33,054	-49%	-$3.96M	0.03%	556
2025 Q2	$7.09M	Buy	66,846 +183	+0.3%	+$19.9K	0.05%	388
2025 Q1	$8.28M	Buy	66,663 +21,844	+49%	+$2.85M	0.07%	306
2024 Q4	$5.52M	Buy	+44,819	New	+$5.28M	0.05%	382
2021 Q4	–	Sell	-729	Closed	-$95K	–	1854
2021 Q3	$95K	Sell	729 -1,052	-59%	-$159K	﹤0.01%	1390
2021 Q2	$316K	Buy	1,781 +164	+10%	+$28.4K	0.01%	831
2021 Q1	$266K	Sell	1,617 -312	-16%	-$51.3K	0.01%	813
2020 Q4	$318K	Buy	1,929 +1,274	+195%	+$190K	0.01%	671
2020 Q3	$93K	Sell	655 -167	-20%	-$20.7K	﹤0.01%	925
2020 Q2	$91K	Buy	822 +817	+16,340%	+$90.3K	﹤0.01%	873
2020 Q1	$0	Sell	5 -29	-85%	-$3.75K	﹤0.01%	1540
2019 Q4	$5K	Buy	+34	New	+$4.63K	﹤0.01%	1449
2016 Q2	–	Sell	-14	Closed	-$2K	–	961
2016 Q1	$2K	Buy	+14	New	+$1.74K	﹤0.01%	873
2015 Q1	–	Sell	-5,877	Closed	-$960K	–	1068
2014 Q4	$960K	Sell	5,877 -9,815	-63%	-$1.63M	0.02%	321
2014 Q3	$2.52M	Sell	15,692 -6,607	-30%	-$1.02M	0.05%	229
2014 Q2	$3.28M	Sell	22,299 -4,422	-17%	-$613K	0.06%	204
2014 Q1	$3.7M	Buy	26,721 +3,797	+17%	+$572K	0.07%	186
2013 Q4	$2.9M	Buy	22,924 +18,114	+377%	+$1.87M	0.06%	201
2013 Q3	$442K	Buy	+4,810	New	+$388K	0.01%	426

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

O'Shaughnessy Asset Management's JAZZ Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 25% in Q2 2026, selling an estimated $1.88M and leaving 25,864 shares worth $6.23M. The position accounts for 0.03% of the portfolio, ranked #495.

O'Shaughnessy Asset Management first reported a position in JAZZ in Q3 2013 and has held it in 22 quarters since. The position peaked at $8.28M in Q1 2025. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

O'Shaughnessy Asset Management held 25,864 shares of Jazz Pharmaceuticals worth $6.23M as of Q2 2026.
O'Shaughnessy Asset Management sold 8,571 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.88M.
Jazz Pharmaceuticals made up 0.03% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #495 holding.
O'Shaughnessy Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 22 quarters since.
O'Shaughnessy Asset Management's Jazz Pharmaceuticals position peaked at $8.28M in Q1 2025.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.